Evidence map›Paper›PMID 26116735›Full record

ReviewThe Journal of infectious diseases2015

Antibodies: At The Nexus of Antigens and Cancer Vaccines.

Zenon Steplewski, Magdalena Thurin, Thomas Kieber-Emmons

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.Monoclonal antibodies in immunodiagnosis and immunotherapy · 2021
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zenon SteplewskiMalvern, Pennsylvania.
Magdalena ThurinCancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Thomas Kieber-EmmonsWinthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock.
Winthrop Rockefeller Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review describes the development of monoclonal antibodies and the inception of their use in cancer therapy, their impact on defining cancer biomarkers, and their structural utility in new cancer vaccine development.

Indexed as

AntibodiesCancer VaccinesNeoplasmsAnimalsAntibodies, MonoclonalAntigens, Tumor-Associated, CarbohydrateBiotechnologyHumansMiceSignal TransductionAntibodiesAntibodies, MonoclonalAntigens, Tumor-Associated, CarbohydrateCancer Vaccinesanti-idiotypesbiotechnologycancer therapeuticscancer vaccinescarbohydrate mimetic peptidesmimicryMonoclonal antibodiesteam science

Identifiers

PMID26116735
PMCPMC4490205
OpenAlexW1941791510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.